224 related articles for article (PubMed ID: 2481712)
1. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
Diez J; Mateu MG; Domingo E
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
[TBL] [Abstract][Full Text] [Related]
2. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
4. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
[TBL] [Abstract][Full Text] [Related]
5. Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine.
Carrillo C; Plana J; Mascarella R; Bergadá J; Sobrino F
Virology; 1990 Dec; 179(2):890-2. PubMed ID: 1700543
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
7. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
8. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
[TBL] [Abstract][Full Text] [Related]
9. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
[TBL] [Abstract][Full Text] [Related]
10. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
11. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle.
Gebauer F; de la Torre JC; Gomes I; Mateu MG; Barahona H; Tiraboschi B; Bergmann I; de Mello PA; Domingo E
J Virol; 1988 Jun; 62(6):2041-9. PubMed ID: 2835508
[TBL] [Abstract][Full Text] [Related]
12. In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies.
Carrillo C; Borca M; Moore DM; Morgan DO; Sobrino F
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1699-706. PubMed ID: 9680133
[TBL] [Abstract][Full Text] [Related]
13. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance.
Borrego B; Camarero JA; Mateu MG; Domingo E
Viral Immunol; 1995; 8(1):11-8. PubMed ID: 8546800
[TBL] [Abstract][Full Text] [Related]
14. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site.
Feigelstock D; Mateu MG; Piccone ME; De Simone F; Brocchi E; Domingo E; Palma EL
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3307-11. PubMed ID: 1335031
[TBL] [Abstract][Full Text] [Related]
15. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.
Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E
Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442
[TBL] [Abstract][Full Text] [Related]
16. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
[TBL] [Abstract][Full Text] [Related]
17. Response of foot-and-mouth disease virus C3 Resende to immunological pressure exerted in vitro by antiviral polyclonal sera.
Schiappacassi M; Rieder Rojas E; Carrillo E; Campos R
Virus Res; 1995 Apr; 36(1):77-85. PubMed ID: 7542827
[TBL] [Abstract][Full Text] [Related]
18. Differential restrictions on antigenic variation among antigenic sites of foot-and-mouth disease virus in the absence of antibody selection.
Holguín A; Hernández J; Martínez MA; Mateu MG; Domingo E
J Gen Virol; 1997 Mar; 78 ( Pt 3)():601-9. PubMed ID: 9049411
[TBL] [Abstract][Full Text] [Related]
19. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
